{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:27:14Z","timestamp":1785472034770,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/ki.2013.194","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T12:44:54Z","timestamp":1369226694000},"page":"713-721","source":"Crossref","is-referenced-by-count":34,"title":["Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease"],"prefix":"10.1016","volume":"84","author":[{"given":"Shiqin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Gillihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiguang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason R.","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.194_bb0010","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.194_bb0015","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2013.194_bb0020","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","article-title":"Calcium deficiency reduces circulating levels of FGF23","volume":"23","author":"Rodriguez-Ortiz","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.194_bb0025","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","article-title":"Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism","volume":"18","author":"Kawata","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.194_bb0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ndt\/gfp699","article-title":"Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study","volume":"25","author":"Ix","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.194_bb0035","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.194_bb0040","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00467-011-1810-4","article-title":"Is fibroblast growth factor 23 a harbinger of mortality in CKD?","volume":"27","author":"Stubbs","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2013.194_bb0045","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/ki.2011.27","article-title":"Phosphate and FGF-23","volume":"121","author":"Juppner","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2013.194_bb0050","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10 burning questions on FGF23 in kidney disease","volume":"21","author":"Wolf","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.194_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"Stubbs","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2013.194_bb0060","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.194_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.194_bb0070","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.194_bb0075","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1083\/jcb.135.5.1403","article-title":"Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome","volume":"135","author":"Miner","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1038\/ki.2013.194_bb0080","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0002-9440(10)64892-4","article-title":"Quantitative trait loci influence renal disease progression in a mouse model of Alport syndrome","volume":"160","author":"Andrews","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1038\/ki.2013.194_bb0085","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.194_bb0090","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2215\/CJN.02640310","article-title":"Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the \u201ctrade-off\u201d hypothesis","volume":"5","author":"Gutierrez","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.194_bb0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2010.168","article-title":"Dysregulation of renal vitamin D metabolism in the uremic rat","volume":"78","author":"Helvig","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.194_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2010.03.065","article-title":"Vitamin D analogues targeting CYP24 in chronic kidney disease","volume":"121","author":"Posner","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1038\/ki.2013.194_bb0105","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/S0021-9258(17)33513-5","article-title":"Stimulation of 25-hydroxyvitamin D3-1alpha-hydroxylase by phosphate depletion","volume":"251","author":"Baxter","year":"1976","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2013.194_bb0110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0003-9861(73)90010-6","article-title":"The control of 25-hydroxyvitamin D metabolism by inorganic phosphorus","volume":"154","author":"Tanaka","year":"1973","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/ki.2013.194_bb0115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.1188357","article-title":"Regulation of serum 1alpha,25-dihydroxyvitamin D3 by calcium and phosphate in the rat","volume":"190","author":"Hughes","year":"1975","journal-title":"Science"},{"key":"10.1038\/ki.2013.194_bb0120","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00467-011-1870-5","article-title":"Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease","volume":"26","author":"Siomou","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2013.194_bb0125","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.194_bb0130","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J"},{"key":"10.1038\/ki.2013.194_bb0135","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/jn\/131.12.3182","article-title":"The progression of aging in klotho mutant mice can be modified by dietary phosphorus and zinc","volume":"131","author":"Morishita","year":"2001","journal-title":"J Nutr"},{"key":"10.1038\/ki.2013.194_bb0140","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ndt\/gfm672","article-title":"Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23","volume":"23","author":"Marsell","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.194_bb0145","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","article-title":"Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome","volume":"10","author":"Cosgrove","year":"1996","journal-title":"Genes Dev"},{"key":"10.1038\/ki.2013.194_bb0150","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/en.2009-0216","article-title":"Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator","volume":"150","author":"David","year":"2009","journal-title":"Endocrinology"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815560341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815560341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T17:26:26Z","timestamp":1645118786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815560341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0085253815560341"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.194","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}